CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,247,000 | +346.6% | 62,848 | +114.1% | 0.01% | +350.0% |
| Q2 2022 | $727,000 | -53.0% | 29,349 | -52.4% | 0.00% | -60.0% |
| Q1 2022 | $1,546,000 | -62.0% | 61,701 | -44.8% | 0.01% | -61.5% |
| Q4 2021 | $4,070,000 | +667.9% | 111,788 | +260.6% | 0.01% | +550.0% |
| Q3 2021 | $530,000 | -10.9% | 31,000 | +222.9% | 0.00% | 0.0% |
| Q4 2020 | $595,000 | +91.9% | 9,600 | +69.6% | 0.00% | 0.0% |
| Q3 2020 | $310,000 | +50.5% | 5,662 | -61.7% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | +5.1% | 14,800 | +2.8% | 0.00% | +100.0% |
| Q1 2018 | $196,000 | +256.4% | 14,400 | +144.1% | 0.00% | – |
| Q2 2017 | $55,000 | -28.6% | 5,900 | -44.3% | 0.00% | -100.0% |
| Q1 2017 | $77,000 | -75.9% | 10,600 | -75.5% | 0.00% | -50.0% |
| Q4 2016 | $320,000 | – | 43,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |